{"nct_id":"NCT01365455","title":"Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2011-06","start_date_type":null,"primary_completion_date":"2013-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}